Fiche du document
2015
- doi: 10.1186/s12883-015-0449-3
- issn: 1471-2377
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1186/s12883-015-0449-3
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/26444858
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1471-2377
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_5DFF23E46ADD9
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
Family Family structure Families--Social aspects Families--Social conditions Family life Structure, Family Family relationships Relationships, FamilyCiter ce document
J.A. Petersen et al., « Dysferlinopathy in Switzerland: clinical phenotypes and potential founder effects. », Serveur académique Lausannois, ID : 10.1186/s12883-015-0449-3
Métriques
Partage / Export
Résumé
BACKGROUND: Dysferlin is reduced in patients with limb girdle muscular dystrophy type 2B, Miyoshi myopathy, distal anterior compartment myopathy, and in certain Ethnic clusters. METHODS: We evaluated clinical and genetic patient data from three different Swiss Neuromuscular Centers. RESULTS: Thirteen patients from 6 non-related families were included. Age of onset was 18.8 ± 4.3 years. In all patients, diallelic disease-causing mutations were identified in the DYSF gene. Nine patients from 3 non-related families from Central Switzerland carried the identical homozygous mutation, c.3031 + 2 T>C. A possible founder effect was confirmed by haplotype analysis. Three patients from two different families carried the heterozygous mutation, c.1064_1065delAA. Two novel mutations were identified (c.2869 C>T (p.Gln957Stop), c.5928 G>A (p.Trp1976Stop)). CONCLUSIONS: Our study confirms the phenotypic heterogeneity associated with DYSF mutations. Two mutations (c.3031 + 2 T>C, c.1064_1065delAA) appear common in Switzerland. Haplotype analysis performed on one case (c. 3031 + 2 T>C) suggested a possible founder effect.